AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration. - Wikidata - awgldk - TriplyDB

AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.

AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.

http://www.wikidata.org/entity/Q37845381

about

Accelerator MS: its role as a frontline bioanalytical technique.Application of a tiered approach to the validation of accelerator MS assays.Adding value through accelerator mass spectrometry-enabled first in human studies.New frontiers-accelerator mass spectrometry (AMS): Recommendation for best practices and harmonization from Global Bioanalysis Consortium Harmonization Team.European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.Predicting drug candidate victims of drug-drug interactions, using microdosing.Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms.Conference report: Discussion on harmonization and globalization of bioanalytical guidances at the 19th International Reid Bioanalytical Forum.

P2860

Q37970117-10073D1A-B3AC-417B-A57B-FAF72D8D011D Q38195301-60E59826-1844-415A-A015-144D5A78D28B Q39573778-F7B085F5-3039-4304-8FDB-9AFA154E1576 Q41812168-6ABFCA99-2E09-4353-89A7-D241A7781F87 Q42679469-BA593CBB-3E71-4A65-BF67-D954B6D93D30 Q45348533-B5575527-9389-450D-A936-B39A66548EDB Q51521654-2123603F-0172-4F6F-98D8-8BDD433F0FE6 Q53139432-2983121C-FC61-43A3-8D49-064639FCD22E

P2860

AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.

http://www.wikidata.org/entity/Q37845381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AMS method validation for quan ...... nd intravenous administration.

@en

AMS method validation for quan ...... nd intravenous administration.

@nl

type

label

AMS method validation for quan ...... nd intravenous administration.

@en

AMS method validation for quan ...... nd intravenous administration.

@nl

prefLabel

AMS method validation for quan ...... nd intravenous administration.

@en

AMS method validation for quan ...... nd intravenous administration.

@nl

P1433

Q37845381-8737DBEF-3F75-4094-ACD8-6ACC7A162509

P1476

Q37845381-2E8D4B7B-362F-4E8C-9B0F-D8449CFBB3CC

P2093

Q37845381-0A4EFD11-9ABA-46E5-8BB0-1A05A6C5AD74

Q37845381-4A98753A-3156-4F98-841A-86DDB13DCD39

Q37845381-8115C169-535B-47E7-998F-12501557113C

Q37845381-90A6303B-CECC-4CA4-A2BE-2B9A8D4C1245

Q37845381-E2961CE2-B689-4498-9114-D3171A9FACDC

P2860

Q37845381-02900900-A1D1-49C1-99E2-E909094D1922

Q37845381-189EF602-33EA-4F8B-9FA4-4042B1679203

Q37845381-34881643-4171-4FC2-8A01-08A7B9E7CFE4

Q37845381-4C192E83-7303-4337-9A8E-6F1B0A6BE80F

Q37845381-4FB787A3-0B6C-43B2-9B4B-80976580F888

Q37845381-76164CF1-6B10-425C-85BC-F3A59C08B59C

Q37845381-8439ADA7-93DA-4C8E-8499-EC703CEA5FEF

Q37845381-9867AB59-F249-4684-9A8C-9B9F84940886

Q37845381-B916808B-5A93-4C04-9F75-BFE36E955882

Q37845381-BCA94F46-FB9F-4E67-B697-A89B31123C6E

P304

Q37845381-550C538B-9155-4621-85A9-3C197348C89C

P31

Q37845381-62CFC47A-5A6B-4421-83AE-85DF0EBE58DC

P356

Q37845381-6396CDD2-37D8-44CA-96C6-222F4A088FF7

P433

Q37845381-A35F3BB7-4297-4694-AFD6-56D9D8053DB0

P478

Q37845381-C334370B-A84F-46C1-87A9-74367EA0F7DA

P577

Q37845381-0B6AB21B-4DC5-4076-B25F-F543FF1C72ED

P698

Q37845381-9A7F9F53-F16C-4576-9E04-34D0110DC305

P356

P1433

P1476

AMS method validation for quan ...... nd intravenous administration.

@en

P2093

David Higton

http://www.w3.org/2001/XMLSchema#string

Graeme Young

http://www.w3.org/2001/XMLSchema#string

Graham Lappin

http://www.w3.org/2001/XMLSchema#string

Howard M Hill

http://www.w3.org/2001/XMLSchema#string

Mark Seymour

http://www.w3.org/2001/XMLSchema#string

P2860

Analytical validation of accelerator mass spectrometry for pharmaceutical development

Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.

The use of isotopes in the determination of absolute bioavailability of drugs in humans.

Quantitating isotopic molecular labels with accelerator mass spectrometry.

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.

Early human ADME using microdoses and microtracers: bioanalytical considerations.

Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique.

Biological accelerator mass spectrometry at Uppsala University.

Subattomole sensitivity in biological accelerator mass spectrometry.

P304

393-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO.11.5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21338259

http://www.w3.org/2001/XMLSchema#string